Cellular and molecular dynamics in the foreign body reaction

Tissue Engineering

Volumn 12, Issue 7, 2006, Pages 1955-1970

  Luttikhuizen, Daniël T ^a   Harmsen, Martin C ^a   Van Luyn, Marja J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL EQUIPMENT; CELLS; IMPLANTS (SURGICAL); INFILTRATION; MOLECULAR DYNAMICS; TISSUE;

CELLULAR PROCESSES; FOREIGN BODY REACTION (FBR); INFLAMMATORY CELLS; MATRIX METALLOPROTEINASES (MMP);

ANTIGEN-ANTIBODY REACTIONS;

CHEMOKINE; CYTOKINE; MATRIX METALLOPROTEINASE;

ANGIOGENESIS; CELL ACTIVATION; CELL INFILTRATION; CELL MIGRATION; CYTOKINE PRODUCTION; DEVICE; DISEASE COURSE; EXTRAVASATION; FIBROSIS; FOREIGN BODY REACTION; IMMUNOMODULATION; IMPLANT; INFLAMMATION; MOLECULAR DYNAMICS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL MOVEMENT; CHEMOKINES; DISEASE PROGRESSION; FOREIGN-BODY REACTION; GENE EXPRESSION REGULATION; HUMANS; LYMPHOKINES; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PATHOLOGIC; PHAGOCYTOSIS; PROSTHESES AND IMPLANTS;

EID: 33746676842     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.1955     Document Type: Review

References (168)

1. Wilson, C.J., Clegg, R.E., Leavesley, D.I., and Pearcy, M.J. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng. 11, 1, 2005.
2. Tang, L., and Eaton, J.W. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J. Exp. Med. 178, 2147, 1993.
3. Thull, R. Physicochemical principles of tissue material interactions. Biomol. Eng. 19, 43, 2002.
4. Hunt, J.A., Flanagan, B.F., McLaughlin, P.J., Strickland, I., and Williams, D.F. Effect of biomaterial surface charge on the inflammatory response: evaluation of cellular infiltration and TNF alpha production. J. Biomed. Mater. Res. 31, 139, 1996.
5. DeFife, K.M., Colton, E., Nakayama, Y., Matsuda, T., and Anderson, J.M. Spatial regulation and surface chemistry control of monocyte/macrophage adhesion and foreign body giant cell formation by photochemically micropatterned surfaces. J. Biomed. Mater. Res. 45, 148, 1999.
6. Pankowsky, D.A., Ziats, N.P., Topham, N.S., Ratnoff, O.D., and Anderson, J.M. Morphologic characteristics of adsorbed human plasma proteins on vascular grafts and biomaterials. J. Vasc. Surg. 11, 599, 1990.
7. Andrade, J.D., and Hlady, V. Plasma protein adsorption: the big twelve. Ann. N. Y. Acad. Sci. 516, 158, 1987.
8. Gorbet, M.B., and Sefton, M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25, 5681, 2004.
9. Wettero, J., Askendal, A., Bengtsson, T., and Tengvall, P. On the binding of complement to solid artificial surfaces in vitro. Biomaterials 23, 981, 2002.
10. Jenney, C.R., and Anderson, J.M. Adsorbed IgG: a potent adhesive substrate for human macrophages. J. Biomed. Mater. Res. 50, 281, 2000.
11. Szaba, F.M., and Smiley, S.T. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99, 1053, 2002.
12. Richardson, D.L., Pepper, D.S., and Kay, A.B. Chemotaxis for human monocytes by fibrinogen-derived peptides. Br. J. Haematol. 32, 507, 1976.
13. Smiley, S.T., King, J.A., and Hancock, W.W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167, 2887, 2001.
14. Li, J., Zhang, Y.P., and Kirsner, R.S. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60, 107, 2003.
15. Lishko, V.K., Podolnikova, N.P., Yakubenko, V.P., Yakovlev, S., Medved, L., Yadav, S.P., and Ugarova, T.P. Multiple binding sites in fibrinogen for integrin alphaMbeta2 (Mac-1). J. Biol. Chem. 279, 44897, 2004.
16. Hu, W.J., Eaton, J.W., Ugarova, T.P., and Tang, L. Molecular basis of biomaterial-mediated foreign body reactions. Blood 98, 1231, 2001.
17. Tang, L., and Eaton, J.W. Natural responses to unnatural materials: a molecular mechanism for foreign body reactions. Mol. Med. 5, 351, 1999.
18. Tang, L., Liu, L., and Elwing, H.B. Complement activation and inflammation triggered by model biomaterial surfaces. J. Biomed. Mater. Res. 41, 333, 1998.
19. Pangburn, M.K., Pangburn, K.L., Koistinen, V., Meri, S., and Sharma, A.K. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement. J. Immunol. 164, 4742, 2000.
20. Janatova, J. Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers. ASAIO J. 46, S53, 2000.
21. Bjork, J., Hugli, T.E., and Smedegard, G. Microvascular effects of anaphylatoxins C3a and C5a. J. Immunol. 134, 1115, 1985.
22. Gillitzer, R., and Goebeler, M. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69, 513, 2001.
23. Parkin, J., and Cohen, B. An overview of the immune system. Lancet 357, 1777, 2001.
24. Bootle-Wilbraham, C.A., Tazzyman, S., Thompson, W.D., Stirk, C.M., and Lewis, C.E. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 4, 269, 2001.
25. Ghosh, A.K., Hirasawa, N., Ohtsu, H., Watanabe, T., and Ohuchi, K. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J. Exp. Med. 195, 973, 2002.
26. Addison, C.L., Daniel, T.O., Burdick, M.D., Liu, H., Ehlert, J.E., Xue, Y.Y., Buechi, L., Walz, A., Richmond, A., and Stricter, R.M. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J. Immunol. 165, 5269, 2000.
27. Scapini, P., Morini, M., Tecchio, C., Minghelli, S., Di Carlo, E., Tanghetti, E., Albini, A., Lowell, C., Berton, G., Noonan, D.M., and Cassatella, M.A. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J. Immunol. 172, 5034, 2004.
28. McCourt, M., Wang, J.H., Sookhai, S., and Redmond, H.P. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch. Surg. 134, 1325, 1999.
29. Banks, R.E., Forbes, M.A., Kinsey, S.E., Stanley, A., Ingham, E., Walters, C., and Selby, P.J. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer 77, 956, 1998.
30. Ferrara, N., Gerber, H.P., and LeCouter, J. The biology of VEGF and its receptors. Nat. Med. 9, 669, 2003.
31. Pugh, C.W., and Ratcliffe, P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677, 2003.
32. Carmeliet, P. Angiogenesis in health and disease. Nat. Med. 9, 653, 2003.
33. Jain, R.K. Molecular regulation of vessel maturation. Nat. Med. 9, 685, 2003.
34. Ganta, S.R., Piesco, N.P., Long, P., Gassner, R., Motta, L.F., Papworth, G.D., Stolz, D.B., Watkins, S.C., and Agarwal, S. Vascularization and tissue infiltration of a biodegradable polyurethane matrix. J. Biomed. Mater. Res. A 64, 242, 2003.
35. Hodde, J.P., Record, R.D., Liang, H.A., and Badylak, S.F. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 8, 11, 2001.
36. Peters, M.C., Polverini, P.J., and Mooney, D.J. Engineering vascular networks in porous polymer matrices. J. Biomed. Mater. Res. 60, 668, 2002.
37. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19, 1029, 2001.
38. Davis, M.E., Hsieh, P.C., Grodzinsky, A.J., and Lee, R.T. Custom design of the cardiac microenvironment with biomaterials. Circ. Res. 97, 8, 2005.
39. Ehrbar, M., Djonov, V.G., Schnell, C., Tschanz, S.A., Martiny-Baron, G., Schenk, U., Wood, J., Burri, P.H., Hubbell, J.A., and Zisch, A.H. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ. Res. 94, 1124, 2004.
40. Kaushal, S., Amiel, G.E., Guleserian, K.J., Shapira, O.M., Perry, T., Sutherland, F.W., Rabkin, E., Moran, A.M., Schoen, F.J., Atala, A., Soker, S., Bischoff, J., and Mayer, J.E., Jr. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med. 7, 1035, 2001.
41. Wu, X., Rabkin-Aikawa, E., Guleserian, K.J., Perry, T.E., Masuda, Y., Sutherland, F.W., Schoen, F.J., Mayer, J.E., Jr., and Bischoff, J. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 287, H480, 2004.
42. Luster, A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338, 436, 1998.
43. Johnston, B., and Butcher, E.C. Chemokines in rapid leukocyte adhesion triggering and migration. Semin. Immunol. 14, 83, 2002.
44. Romagnani, P., Lasagni, L., Annunziato, F., Serio, M., and Romagnani, S. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol. 25, 201, 2004.
45. Rot, A., and von Andrian, U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891, 2004.
46. Engelhardt, E., Toksoy, A., Goebeler, M., Debus, S., Brocker, E.B., and Gillitzer, R. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am. J. Pathol. 153, 1849, 1998.
47. Armstrong, D.A., Major, J.A., Chudyk, A., and Hamilton, T.A. Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J. Leukoc. Biol. 75, 641, 2004.
48. Brodbeck, W.G., Voskerician, G., Ziats, N.P., Nakayama, Y., Matsuda, T., and Anderson, J.M. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J. Biomed. Mater. Res. A 64, 320, 2003.
49. Vaday, G.G., Franitza, S., Schor, H., Hecht, I., Brill, A., Cahalon, L., Hershkoviz, R., and Lider, O. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J. Leukoc. Biol. 69, 885, 2001.
50. Gerard, C., and Rollins, B.J. Chemokines and disease. Nat. Immunol. 2, 108, 2001.
51. Ferreira, A.M., Rollins, B.J., Faunce, D.E., Burns, A.L., Zhu, X., and DiPietro, L.A. The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation. Cytokine 30, 64, 2005.
52. Mantovani, A. The chemokine system: redundancy for robust outputs. Immunol. Today 20, 254, 1999.
53. Tang, L., Jennings, T.A., and Eaton, J.W. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc. Natl. Acad. Sci. U. S. A. 95, 8841, 1998.
54. Tao, F., and Kobzik, L. Lung macrophage-epithelial cell interactions amplify particle-mediated cytokine release. Am. J. Respir. Cell Mol. Biol. 26, 499, 2002.
55. Huang, S., Paulauskis, J.D., Godleski, J.J., and Kobzik, L. Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am. J. Pathol. 141, 981, 1992.
56. Devalaraja, R.M., Nanney, L.B., Du, J., Qian, Q., Yu, Y., Devalaraja, M.N., and Richmond, A. Delayed wound healing in CXCR2 knockout mice. J. Invest. Dermatol. 115, 234, 2000.
57. Milatovic, S., Nanney, L.B., Yu, Y., White, J.R., and Richmond, A. Impaired healing of nitrogen mustard wounds in CXCR2 null mice. Wound Repair Regen. 11, 213, 2003.
58. Murdoch, C., and Finn, A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95, 3032, 2000.
59. Ludwig, A., Petersen, F., Zahn, S., Gotze, O., Schroder, J.M., Flad, H.D., and Brandt, E. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 90, 4588, 1997.
60. Lassus, J., Waris, V., Xu, J.W., Li, T.F., Hao, J., Nietosvaara, Y., Santavirta, S., and Konttinen, Y.T. Increased interleukin-8 (IL-8) expression is related to aseptic loosening of total hip replacement. Arch. Orthop. Trauma Surg. 120, 328, 2000.
61. Crowe, M.J., Doetschman, T., and Greenhalgh, D.G. Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J. Invest. Dermatol. 115, 3, 2000.
62. DiPietro, L.A., Burdick, M., Low, Q.E., Kunkel, S.L., and Stricter, R.M. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J. Clin. Invest. 101, 1693, 1998.
63. Volin, M.V., Shah, M.R., Tokuhira, M., Haines, G.K., Woods, J.M., and Koch, A.E. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin. Immunol. Immunopathol. 89, 44, 1998.
64. Hancock, W.W., Gao, W., Faia, K.L., and Csizmadia, V. Chemokines and their receptors in allograft rejection. Curr. Opin. Immunol. 12, 511, 2000.
65. Ono, S.J., Nakamura, T., Miyazaki, D., Ohbayashi, M., Dawson, M., and Toda, M. Chemokines: roles in leukocyte development, trafficking, and effector function. J. Allergy Clin. Immunol. 111, 1185, 2003.
66. Maurer, M., and von Stebut, E. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 36, 1882, 2004.
67. Lu, B., Rutledge, B.J., Gu, L., Fiorillo, J., Lukacs, N.W., Kunkel, S.L., North, R., Gerard, C., and Rollins, B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187, 601, 1998.
68. Valente, A.J., Graves, D.T., Vialle-Valentin, C.E., Delgado, R., and Schwartz, C.J. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27, 4162, 1988.
69. Rutledge, B.J., Rayburn, H., Rosenberg, R., North, R.J., Gladue, R.P., Corless, C.L., and Rollins, B.J. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J. Immunol. 155, 4838, 1995.
70. Low, Q.E., Drugea, I.A., Duffner, L.A., Quinn, D.G., Cook, D.N., Rollins, B.J., Kovacs, E.J., and DiPietro, L.A. Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am. J. Pathol. 159, 457, 2001.
71. Kuziel, W.A., Morgan, S.J., Dawson, T.C., Griffin, S., Smithies, O., Ley, K., and Maeda, N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. U. S. A. 94, 12053, 1997.
72. Kyriakides, T.R., Foster, M.J., Keeney, G.E., Tsai, A., Giachelli, C.M., Clark-Lewis, I., Rollins, B.J., and Bornstein, P. The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am. J. Pathol. 165, 2157, 2004.
73. Weber, C., Belge, K.U., von Hundelshausen, P., Draude, G., Steppich, B., Mack, M., Frankenberger, M., Weber, K.S., and Ziegler-Heitbrock, H.W. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67, 699, 2000.
74. Rhodes, N.P., Hunt, J.A., and Williams, D.F. Macrophage subpopulation differentiation by stimulation with biomaterials. J. Biomed. Mater. Res. 37, 481, 1997.
75. Geissmann, F., Jung, S., and Littman, D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71, 2003.
76. Niiyama, H., Kai, H., Yamamoto, T., Shimada, T., Sasaki, K., Murohara, T., Egashira, K., and Imaizumi, T. Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization. J. Am. Coll. Cardiol. 44, 661, 2004.
77. Boomker, J.M., Luttikhuizen, D.T., Veninga, H., de Leij, L.F., The, T.H., de Haan, A., van Luyn, M.J., and Harmsen, M.C. The modulation of angiogenesis in the foreign body response by the poxviral protein M-T7. Biomaterials 26, 4874, 2005.
78. Taub, D.D., Conlon, K., Lloyd, A.R., Oppenheim, J.J., and Kelvin, D.J. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 260, 355, 1993.
79. Makino, Y., Cook, D.N., Smithies, O., Hwang, O.Y., Neilson, E.G., Turka, L.A., Sato, H., Wells, A.D., and Danoff, T.M. Impaired T cell function in RANTES-deficient mice. Clin. Immunol. 102, 302, 2002.
80. Anderson, J.M. Multinucleated giant cells. Curr. Opin. Hematol. 7, 40, 2000.
81. DeFife, K.M., Jenney, C.R., McNally, A.K., Colton, E., and Anderson, J.M. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol. 158, 3385, 1997.
82. McNally, A.K., and Anderson, J.M. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am. J. Pathol. 147, 1487, 1995.
83. Ozaki, K., and Leonard, W.J. Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem. 277, 29355, 2002.
84. Schroder, K., Hertzog, P.J., Ravasi, T., and Hume, D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163, 2004.
85. Khouw, I.M., van Wachem, P.B., de Leij, L.F., and van Luyn, M.J. Inhibition of the tissue reaction to a biodegradable biomaterial by monoclonal antibodies to IFN-gamma. J. Biomed. Mater. Res. 41, 202, 1998.
86. Khouw, I.M., van Wachem, P.B., Plantinga, J.A., de Leij, L.F., and van Luyn, M.J. Enzyme and cytokine effects on the impaired onset of the murine foreign-body reaction to dermal sheep collagen. J. Biomed. Mater. Res. 54, 234, 2001.
87. Brodbeck, W.G., Nakayama, Y., Matsuda, T., Colton, E., Ziats, N.P., and Anderson, J.M. Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro. Cytokine 18, 311, 2002.
88. Marinucci, L., Lilli, C., Guerra, M., Beicastro, S., Becchetti, E., Stabellini, G., Calvi, E.M., and Locci, P. Biocompatibility of collagen membranes crosslinked with glutaraldehyde or diphenylphosphoryl azide: an in vitro study. J. Biomed. Mater. Res. A 67, 504, 2003.
89. Ung, D.Y., Woodhouse, K.A., and Sefton, M.V. Tumor necrosis factor (TNFalpha) production by rat peritoneal macrophages is not polyacrylate surface-chemistry dependent. J. Biomed. Mater. Res. 46, 324, 1999.
90. Anderson, J.M., Ziats, N.P., Azeez, A., Brunstedt, M.R., Stack, S., and Bonfield, T.L. Protein adsorption and macrophage activation on polydimethylsiloxane and silicone rubber. J. Biomater. Sci. Polym. Ed. 7, 159, 1995.
91. Boynton, E.L., Waddell, J., Meek, E., Labow, R.S., Edwards, V., and Santerre, J.P. The effect of polyethylene particle chemistry on human monocyte-macrophage function in vitro. J. Biomed. Mater. Res. 52, 239, 2000.
92. Yaszay, B., Trindade, M.C., Lind, M., Goodman, S.B., and Smith, R.L. Fibroblast expression of C-C chemokines in response to orthopaedic biomaterial particle challenge in vitro. J. Orthop. Res. 19, 970, 2001.
93. Schachtrupp, A., Klinge, U., Junge, K., Rosch, R., Bhardwaj, R.S., and Schumpelick, V. Individual inflammatory response of human blood monocytes to mesh biomaterials. Br. J. Surg. 90, 114, 2003.
94. Cardona, M.A., Simmons, R.L., and Kaplan, S.S. TNF and IL-1 generation by human monocytes in response to biomaterials. J. Biomed. Mater. Res. 26, 851, 1992.
95. Daniels, A.U., Barnes, F.H., Charlebois, S.J., and Smith, R.A. Macrophage cytokine response to particles and lipppolysaccharide in vitro. J. Biomed. Mater. Res. 49, 469, 2000.
96. Prabhu, A., Shelburne, C.E., and Gibbons, D.F. Cellular proliferation and cytokine responses of murine macrophage cell line J774A.1 to polymethylmethacrylate and cobalt-chrome alloy particles. J. Biomed. Mater. Res. 42, 655, 1998.
97. Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X.F., and Achong, M.K. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311, 1998.
98. Tilg, H., Trehu, E., Atkins, M.B., Dinarello, C.A., and Mier, J.W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83, 113, 1994.
99. Steensberg, A., Fischer, C.P., Keller, C., Moller, K., and Pedersen, B.K. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am. J. Physiol. Endocrinol. Metab. 285, E433, 2003.
100. Hurst, S.M., Wilkinson, T.S., McLoughlin, R.M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G.M., Topley, N., and Jones, S.A. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14, 705, 2001.
101. Jones, S.A., Horiuchi, S., Topley, N., Yamamoto, N., and Fuller, G.M. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15, 43, 2001.
102. Biswas, R., Datta, S., Gupta, J.D., Novotny, M., Tebo, J., and Hamilton, T.A. Regulation of chemokine mRNA stability by lipopolysaccharide and IL-10. J. Immunol. 170, 6202, 2003.
103. Murray, P.J. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. U. S. A. 102, 8686, 2005.
104. Kim, H.S., Armstrong, D., Hamilton, T.A., and Tebo, J.M. IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. J. Leukoc. Biol. 64, 33, 1998.
105. Ajuebor, M.N., Das, A.M., Virag, L., Szabo, C., and Perretti, M. Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem. Biophys. Res. Commun. 255, 279, 1999.
106. D'Amico, G., Frascaroli, G., Bianchi, G., Transidico, P., Doni, A., Vecchi, A., Sozzani, S., Allavena, P., and Mantovani, A. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. 1, 387, 2000.
107. Popi, A.F., Lopes, J.D., and Mariano, M. Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro. Immunology 113, 348, 2004.
108. Kelly, J.L., Lyons, A., Soberg, C.C., Mannick, J.A., and Lederer, J.A. Anti-interleukin-10 antibody restores burn-induced defects in T-cell function. Surgery 122, 146, 1997.
109. Ayala, A., Lehman, D.L., Herdon, C.D., and Chaudry, I.H. Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release. Arch. Surg. 129, 1172, 1994.
110. Song, G.Y., Chung, C.S., Chaudry, I.H., and Ayala, A. What is the role of interleukin 10 in polymicrobial sepsis: antiinflammatory agent or immunosuppressant? Surgery 126, 378, 1999.
111. Platt, N., and Gordon, S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? The mouse's tale. J. Clin. Invest. 108, 649, 2001.
112. Arredouani, M., Yang, Z., Ning, Y., Qin, G., Soininen, R., Tryggvason, K., and Kobzik, L. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J. Exp. Med. 200, 267, 2004.
113. Honma, T., and Hamasaki, T. Ultrastructure of multi-nucleated giant cell apoptosis in foreign-body granuloma. Virchows Arch. 428, 165, 1996.
114. Kaji, Y., Ikeda, K., Ikeda, T., Kawakami, K., Sasaki, K., Shindo, M., Hatake, K., Harada, M., Motoyoshi, K., Mori, S., Norimatsu, H., and Takahara, J. IL-4, but not vitamin D(3), induces monoblastic cell line UG3 to differentiate into multinucleated giant cells on osteoclast lineage. J. Cell Physiol. 182, 214, 2000.
115. Fais, S., Burgio, V.L., Silvestri, M., Capobianchi, M.R., Pacchiarotti, A., and Pallone, F. Multinucleated giant cells generation induced by interferon-gamma. Changes in the expression and distribution of the intercellular adhesion molecule-1 during macrophages fusion and multinucleated giant cell formation. Lab. Invest. 71, 737, 1994.
116. Chiozzi, P., Sanz, J.M., Ferrari, D., Falzoni, S., Aleotti, A., Buell, G.N., Collo, G., and Di Virgilio, F. Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. J. Cell Biol. 138, 697, 1997.
117. Vignery, A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int. J. Exp. Pathol. 81, 291, 2000.
118. Sterling, H., Saginario, C., and Vignery, A. CD44 occupancy prevents macrophage multinucleation. J. Cell Biol. 143, 837, 1998.
119. Bonnema, H., Popa, E.R., van Timmeren, M.M., van Wachem, P.B., de Leij, L.F., and van Luyn, M.J. Distribution patterns of the membrane glycoprotein CD44 during the foreign-body reaction to a degradable biomaterial in rats and mice. J. Biomed. Mater. Res. A 64, 502, 2003.
120. Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., Oike, Y., Takeya, M., Toyama, Y., and Suda, T. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202, 345, 2005.
121. Chakraborti, S., Mandal, M., Das, S., Mandal, A., and Chakraborti, T. Regulation of matrix metalloproteinases: an overview. Mol. Cell Biochem. 253, 269, 2003.
122. Warner, R.L., Bhagavathula, N., Nerusu, K.C., Lateef, H., Younkin, E., Johnson, K.J., and Varani, J. Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. Exp. Mol. Pathol. 76, 189, 2004.
123. Vu, T.H., and Werb, Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14, 2123, 2000.
124. Skiles, J.W., Gonnella, N.C., and Jeng, A.Y. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors. Curr. Med. Chem. 11, 2911, 2004.
125. Beaudeux, J.L., Giral, P., Bruckert, E., Foglietti, M.J., and Chapman, M.J. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives. Clin. Chem. Lab. Med. 42, 121, 2004.
126. McQuibban, G.A., Gong, J.H., Wong, J.P., Wallace, J.L., Clark-Lewis, I., and Overall, C.M. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100, 1160, 2002.
127. Schonbeck, U., Mach, F., and Libby, P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J. Immunol., 161, 3340, 1998.
128. Patterson, B.C., and Sang, Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272, 28823, 1997.
129. Lijnen, H.R., Ugwu, F., Bini, A., and Collen, D. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37, 4699, 1998.
130. Dong, Z., Kumar, R., Yang, X., and Fidler, I.J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801, 1997.
131. Chavakis, T., Athanasopoulos, A., Rhee, J.S., Orlova, V., Schmidt-Woll, T., Bierhaus, A., May, A.E., Celik, I., Nawroth, P.P., and Preissner, K.T. Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment. Blood 105, 1036, 2005.
132. Border, W.A., and Noble, N.A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331, 1286, 1994.
133. Reunanen, N., Li, S.P., Ahonen, M., Foschi, M., Han, J., and Kahari, V.M. Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J. Biol. Chem. 277, 32360, 2002.
134. Lutolf, M.P., Lauer-Fields, J.L., Schmoekel, H.G., Metters, A.T., Weber, F.E., Fields, G.B., and Hubbell, J.A. Synthetic matrix metalloproteinase- sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc. Natl. Acad. Sci. U. S. A. 100, 5413, 2003.
135. Park, Y., Lutolf, M.P., Hubbell, I.A., Hunziker, E.B., and Wong, M. Bovine primary chondrocyte culture in synthetic matrix metalloproteinase- sensitive poly(ethylene glycol)-based hydrogels as a scaffold for cartilage repair. Tissue Eng. 10, 515, 2004.
136. Lutolf, M.P., Weber, F.E., Schmoekel, H.G., Schense, J.C., Kohler, T., Muller, R., and Hubbell, J.A. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat. Biotechnol. 21, 513, 2003.
137. Dayer, J.M., Beutler, B., and Cerami, A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162, 2163, 1985.
138. Verrecchia, F., and Mauviel, A. TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression. Cell Signal 16, 873, 2004.
139. Ashcroft, G.S. Bidirectional regulation of macrophage function by TGF-beta. Microbes Infect. 1, 1275, 1999.
140. Bellingan, G.J., Caldwell, H., Howie, S.E., Dransfield, I., and Haslett, C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 157, 2577, 1996.
141. Nakatsukasa, H., Nagy, P., Evarts, R.P., Hsia, C.C., Marsden, E., and Thorgeirsson, S.S. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J. Clin. Invest. 85, 1833, 1990.
142. Quaglino, D., Jr., Nanney, L.B., Ditesheim, J.A., and Davidson, J.M. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. J. Invest. Dermatol. 97, 34, 1991.
143. Ignotz, R.A., and Massague, J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261, 4337, 1986.
144. Eckes, B., Zigrino, P., Kessler, D., Holtkotter, O., Shephard, P., Mauch, C., and Krieg, T. Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol. 19, 325, 2000.
145. Hall, M.C., Young, D.A., Waters, J.G., Rowan, A.D., Chantry, A., Edwards, D.R., and Clark, I.M. The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J. Biol. Chem. 278, 10304, 2003.
146. Bonner, J.C. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 15, 255, 2004.
147. McCartney-Francis, N., Mizel, D., Wong, H., Wahl, L., and Wahl, S. TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors 4, 27, 1990.
148. Kuhn, A., Singh, S., Smith, P.D., Ko, F., Falcone, R., Lyle, W.G., Maggi, S.P., Wells, K.E., and Robson, M.C. Periprosthetic breast capsules contain the fibrogenic cytokines TGF-beta1 and TGF-beta2, suggesting possible new treatment approaches. Ann. Plast. Surg. 44, 387, 2000.
149. Mazaheri, M.K., Schultz, G.S., Blalock, T.D., Caffee, H.H., and Chin, G.A. Role of connective tissue growth factor in breast implant elastomer capsular formation. Ann. Plast. Surg. 50, 263, 2003.
150. Ward, W.K., Slobodzian, E.P., Tiekotter, K.L., and Wood, M.D. The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants. Biomaterials 23, 4185, 2002.
151. Sharkawy, A.A., Klitzman, B., Truskey, G.A., and Reichert, W.M. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J. Biomed. Mater. Res. 37, 401, 1997.
152. de Vos, P., van Hoogmoed, C.G., van Zanten, J., Netter, S., Strubbe, J.H., and Busscher, H.J. Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets. Biomaterials 24, 305, 2003.
153. Nakagawa, H., Shiota, S., Takano, K., Shibata, F., and Kato, H. Cytokine-induced neutrophil chemoattractant (CINC)-2 alpha, a novel member of rat GRO/CINCs, is a predominant chemokine produced by lipopolysaccharide- stimulated rat macrophages in culture. Biochem. Biophys. Res. Commun. 220, 945, 1996.
154. Franitza, S., Hershkoviz, R., Kam, N., Lichtenstein, N., Vaday, G.G., Alon, R., and Lider, O. TNF-alpha associated with extracellular matrix fibronectin provides a stop signal for chemotactically migrating T cells. J. Immunol. 165, 2738, 2000.
155. Menten, P., Wuyts, A., and Van Damme, J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13, 455, 2002.
156. Ness, T.L., Carpenter, K.J., Ewing, J.L., Gerard, C.J., Hogaboam, C.M., and Kunkel, S.L. CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis. J. Immunol. 173, 6938, 2004.
157. Hamilton, J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23, 403, 2002.
158. Frucht, D.M., Fukao, T., Bogdan, C., Schindler, H., O'Shea, J.J., and Koyasu, S. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 22, 556, 2001.
159. Arend, W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 13, 323, 2002.
160. Smith, K.A. Interleukin-2: inception, impact, and implications. Science 240, 1169, 1988.
161. Schneider, C.P., Schwacha, M.G., and Chaudry, I.H. The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage. Biochim. Biophys. Acta 1689, 22, 2004.
162. Wu, C.Y., Demeure, C., Kiniwa, M., Gately, M., and Delespesse, G. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J. Immunol. 151, 1938, 1993.
163. Okazaki, T., Ebihara, S., Takahashi, H., Asada, M., Kanda, A., and Sasaki, H. Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis. J. Immunol. 174, 7531, 2005.
164. Schmidt-Weber, C.B., and Blaser, K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr. Opin. Immunol. 16, 709, 2004.
165. Lin, E., Galvano, S.E., and Lowry, S.F. Inflammatory cytokines and cell response in surgery. Surgery 127, 117, 2000.
166. Quinn, C.O., Scott, D.K., Brinckerhoff, C.E., Matrisian, L.M., Jeffrey, J.J., and Partridge, N.C. Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells. J. Biol. Chem. 265, 22342, 1990.
167. Schall, T.J., Bacon, K., Camp, R.D., Kaspari, J.W., and Goeddel, D.V. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177, 1821, 1993.
168. Bernardo, M.M., Brown, S., Li, Z.H., Fridman, R., and Mobashery, S. Design, synthesis, and characterization of potent, slow-binding inhibitors that